Literature DB >> 9543158

The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.

I Schipper1, W C Hop, B C Fauser.   

Abstract

According to the threshold concept, FSH concentrations need to surpass a distinct level to stimulate ovarian follicle growth. The window concept stresses the significance of a limited duration of elevated FSH levels above the threshold for single dominant follicle selection. The aim of this study was to investigate effects on follicle growth of increased FSH levels, differing in duration and magnitude of elevation, during the follicular phase. Twenty-three normo-ovulatory (cycle length, 26-31 days), young (age, 20-31 yr) women volunteered for this study. In all subjects a series of daily transvaginal sonography scans of the ovaries and blood sampling [for FSH and estradiol (E2) determinations] were performed during two consecutive cycles. The first study cycle (control cycle) started 10 days after urinary assessment of the LH surge in the preceding cycle (DayLH) and was concluded on the day of ovulation assessed by transvaginal sonography scans. The second series of daily monitoring (intervention cycle) started 10 days after DayLH in the control cycle. After randomization, subjects received either 375 IU urinary FSH, s.c., as a single injection on Day(LH+14) (group A; n = 11) or 75 IU daily from Day(LH+19) until Day(LH+23) (group B; n = 12). In group A, FSH levels increased on the day after injection to a median concentration of 10.1 IU/L, which was 1.9 times higher (P < 0.01) than levels on matching days during the control cycle. Concentrations returned to basal levels 3 days after injection. In group B, a moderate elevation of FSH concentrations (15% increase; P < 0.05) was observed compared to levels during the control cycle. In group A, E2 concentrations increased (P = 0.03) 1 day after FSH injection and returned to baseline levels within 2 days. In group B, E2 levels started to increase after the first injection of FSH and remained significantly higher (P < 0.01) during the following 5 days compared to those on matching days in the control cycle. Compared to matching days in the control cycle an increased number of follicles 8-10 mm in size was found in group A (P < 0.01) during the period from Day(LH+14) until Day(LH+19), without an increase in follicles 10 mm or larger thereafter. In contrast, in group B, the numbers of both 8- to 10-mm and 10-mm or larger follicles were higher during the period from Day(LH+19) until Day(LH+24) in group B (P = 0.02 and P < 0.01, respectively). Results from the present study suggest that a brief, but distinct, elevation of FSH levels above the threshold in the early follicular phase does not affect dominant follicle development, although the number of small antral follicles did increase. In contrast, a moderate, but continued, elevation of FSH levels during the mid to late follicular phase (effectively preventing decremental FSH concentrations) does interfere with single dominant follicle selection and induces ongoing growth of multiple follicles. These findings substantiate the FSH window concept and support the idea of enhanced sensitivity of more mature follicles for stimulation by FSH. These results may provide the basis for further investigation regarding ovulation induction treatment regimens with reduced complication rates due to overstimulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543158     DOI: 10.1210/jcem.83.4.4710

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only.

Authors:  Fei Gong; Sufen Cai; Shunji Zhang; Changfu Lu; Ge Lin; Guangxiu Lu
Journal:  J Assist Reprod Genet       Date:  2012-02-09       Impact factor: 3.412

2.  Intraovarian arterial blood flow resistance in oligomenorrheal infertile women.

Authors:  Koji Nakagawa; Yuji Takahashi; Megumu Ito; Takashi Horikawa; Shirei Ohgi; Minoru Irahara; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2006-05-12       Impact factor: 3.412

Review 3.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

4.  Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study.

Authors:  Alberto Revelli; Giulia Pittatore; Simona Casano; Stefano Canosa; Francesca Evangelista; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2015-01-15       Impact factor: 3.412

5.  Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.

Authors:  Iro Karagiorga; George A Partsinevelos; Despina Mavrogianni; Elli Anagnostou; Ioannis Zervomanolakis; Konstantinos Kallianidis; Petros Drakakis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2014-12-27       Impact factor: 3.412

6.  Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.

Authors:  F J Huang; S Y Chang; M Y Tsai; F T Kung; J F Wu; H W Chang
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

Review 7.  Progress in understanding human ovarian folliculogenesis and its implications in assisted reproduction.

Authors:  Dong Zi Yang; Wan Yang; Yu Li; Zuanyu He
Journal:  J Assist Reprod Genet       Date:  2013-02       Impact factor: 3.412

8.  Human choriogonadotropin prior to controlled ovarian stimulation and in vitro fertilization improves implantation, and pregnancy rates.

Authors:  Eduardo L Motta; Gary D Smith; Paulo C Serafini; Marcio Coslovsky; Pericles Hassun; Andre M Rocha; Isaac Yadid
Journal:  J Assist Reprod Genet       Date:  2009-06-16       Impact factor: 3.412

9.  Luteal start of exogenous FSH in poor responder women.

Authors:  Tansu Kucuk; Eran Sozen
Journal:  J Assist Reprod Genet       Date:  2007-11-16       Impact factor: 3.412

Review 10.  Contemporary pharmacological manipulation in assisted reproduction.

Authors:  Judith A F Huirne; Cornelis B Lambalk; Andre C D van Loenen; Roel Schats; Peter G A Hompes; Bart C J M Fauser; Nick S Macklon
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.